Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Acrobio Healthcare develops and markets evidence-based nutraceutical products derived from traditional Chinese herbs, supported by clinical research. Their products target women's health issues such as urinary tract infections and bone density loss. The company has obtained patents in the USA, Canada, Japan, Australia, and Taiwan for its inventions. No pharmaceutical clinical trial results or regulatory approvals were found; their focus remains on functional foods/nutraceuticals with some hospital-based studies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Acrobio Healthcare.